Polycythemia Vera  >>  itacitinib (INCB039110)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
itacitinib (INCB039110) / Incyte
NCT01633372: An Open Label Study of Itacitinib Administered Orally in Patients With Myelofibrosis

Completed
2
87
Canada, US, RoW
itacitinib, INCB039110
Incyte Corporation
MPN (Myeloproliferative Neoplasms)
12/13
06/21

Download Options